Overview
Molecular radiotherapy uses radiolabeled agents to treat disease. It delivers targeted radiation to tumors and other lesions. It combines diagnostic imaging with therapy planning.
Clinical Indications
Theranostic pairs match diagnostic tracers with therapeutic agents. Indications include neuroendocrine tumors and prostate cancer. Patient selection and dosimetry are critical for safety.
Delivery and Monitoring
Imaging monitors distribution and response to therapy. Dosimetry guides treatment planning and follow up. Multidisciplinary teams coordinate care and manage toxicity.
Future Prospects
New agents and delivery methods expand therapeutic options. Personalized dosimetry improves efficacy and safety. Research aims to broaden indications and access.